KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Shareholder's Equity (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -103.55%
Dec 31, 2025 -23.77%
Sep 30, 2025 -1,814.49%
Jun 30, 2025 -109.44%
Mar 31, 2025 -56.54%
Dec 31, 2024 -44.59%
Sep 30, 2024 -11.00%
Jun 30, 2024 -15.24%
Mar 31, 2024 -22.60%
Dec 31, 2023 -14.28%
Sep 30, 2023 -5.96%
Jun 30, 2023 -3.04%
Mar 31, 2023 -23.05%
Dec 31, 2022 7.86%
Sep 30, 2022 9.12%
Jun 30, 2022 -9.97%
Mar 31, 2022 5.69%
Dec 31, 2021 13.69%
Sep 30, 2021 7.81%
Jun 30, 2021 -8.29%
Mar 31, 2021 4.86%
Dec 31, 2020 -14.34%
Sep 30, 2020 3.78%
Jun 30, 2020 298.68%
Mar 31, 2020 9.26%
Dec 31, 2019 0.66%
Sep 30, 2019 3.97%
Jun 30, 2019 -9.46%
Mar 31, 2019 7.34%
Dec 31, 2018 -189.15%
Sep 30, 2018 13.45%
Jun 30, 2018 -194.99%
Mar 31, 2018 -30.29%
Dec 31, 2017 441.62%
Sep 30, 2017 -2,764.29%
Jun 30, 2017 104.43%
Mar 31, 2017 -127.29%
Dec 31, 2016 519.17%
Sep 30, 2016 -2,148.15%
Jun 30, 2016 104.99%
Mar 31, 2016 -127.43%
Dec 31, 2015 4,487.21%
Sep 30, 2015 103.62%
Jun 30, 2015 -106.08%
Mar 31, 2015 -166.13%
Dec 31, 2014 290.80%
Sep 30, 2014 -117.50%
Jun 30, 2014 11.09%
Mar 31, 2014 4.56%
Dec 31, 2013 25.58%
Sep 30, 2013 0.53%
Jun 30, 2013 20.32%
Mar 31, 2013 1,533.70%